# Medicare at 50 Act: Plain Language Summary

The Medicare at 50 Act would lower the eligibility age for Medicare from 65 to 50 years old. Currently, Medicare is the federal health insurance program primarily for people 65 and older, regardless of income or health status. This bill would allow people as young as 50 to enroll in the same Medicare program, making it available to a much larger working-age population.

This change would affect millions of Americans in their 50s who currently struggle to find affordable health insurance. Many people in this age group face higher premiums on the private insurance market because they're older and statistically more likely to have health problems. By allowing them to join Medicare at 50, they could potentially access more affordable coverage. However, this would also significantly expand Medicare's costs and enrollment, which could affect the program's finances and potentially impact wait times or services for current beneficiaries.

The bill would require changes to how Medicare is funded and administered to handle the influx of younger enrollees. It would likely increase payroll taxes or require additional government funding to cover the costs of insuring this additional population. For people aged 50-64, this could mean a new option for health coverage, though they might still need to meet certain eligibility requirements or pay premiums to participate in the program.

Medicare at 50 Act

Stabenow, Debbie

Medicare at 50 Act This bill establishes a Medicare buy-in option for certain qualifying individuals and also repeals restrictions relating to prescription drug prices under the Medicare prescription drug benefit. Specifically, the bill allows individuals aged 50 to 64 to enroll in Medicare if such individuals would otherwise qualify for Medicare at the age of 65. The Centers for Medicare &amp; Medicaid Services (CMS) must determine enrollment periods and set premiums for the buy-in option established under the bill, in accordance with specified requirements. The CMS must also award grants to states and nonprofit organizations for outreach and enrollment activities relating to the buy-in option. The bill also repeals provisions that prohibit the CMS from negotiating the prices of prescription drugs or from establishing a formulary under the Medicare prescription drug benefit.